Invest in Canada

Canada is an attractive destination for investors who are looking to capitalize on our innovative business culture, established R&D infrastructure, and talented workforce. 
A global leader in digital radiography, in-vitro diagnostics, cardiovascular devices, dental implants, and home health care, Canada is home to more than 6,000 life sciences companies and the industry employs over 31,000 people in manufacturing alone. Canada is the world’s 8th largest medical device market and the lowest-cost G7 country for companies who specialize in biotechnology, product testing, and clinical trials. The industry plays an important role in Canada’s economy and is supported by both the federal and provincial levels of government with incentive programs covering R&D, capital investments, and hiring a workforce.

In Canada, we have focused on protection and preparation—by protecting everyone’s health and safety and preparing businesses here for transition to economic recovery. 
Although far from perfect, Canada has fared better in dealing with this pandemic than others around the world. As The Washington Post noted in mid-July, while Canada and the United States both confirmed their first cases around the same time in January, Canada has reported, on a per capita basis, about three times fewer infections than the United States and almost half the number of deaths. 
Canada’s relative success in responding to COVID-19 speaks to a culture of respect for the life sciences, for professional medical advice, and for each other. As pointed out in that Washington Post article, “The Canadian people have been less divided and more disciplined” over measures to slow the spread of COVID-19. 

On December 30, 2019, Toronto-based BlueDot informed its clients about unusual pneumonia cases detected around a market in Wuhan. Using artificial intelligence, the company’s platform predicts the spread of infectious diseases. It was the first to predict the COVID-19 outbreak.
Three months later, companies everywhere in Canada are finding new ways to join the fight and are spearheading a global movement of collaboration. While biotech companies search for a cure, manufacturers are repurposing their production lines to supply medical gear and tech companies are pitching in to support healthcare professionals, small businesses and Canadians.
Times may feel uncertain, but one thing is clear, Canada stands strong in resilience.